Millions of people who have refused to get an experimental mRNA vaccine may soon be forced to consume the gene therapy in their food.
Researchers at the University of California were awarded a $500,000 grant from the National Science Foundation developing technology that infuses experimental mRNA Covid-19 vaccines into spinach, lettuce and other edible plants.
The team of nanobiotechnology experts is currently working on successfully delivering DNA containing mRNA BioNTech technology into chloroplasts, the part of the plants that instruct its cells’ DNA to replicate the vaccine material.
Mad scientists have been planning vaccines in food for a long time...
GRAIN | EAT UP YOUR VACCINES
(Year 2000) All the major agbiotech giants – such as Syngenta (the new Novartis/AstraZeneca agribusiness merger), Monsanto and Aventis – are investing heavily in functional foods. Their agenda is clear. Daniel Vasella, chairman and CEO of Novartis, echoes the hopes of the whole industry in his belief that "tangible consumer benefits could turn the debate on genetically modified food."
Some of the more ambitious functional foods in the pipeline are those with pharmaceutical applications.
Food: How Altered?
Scientists continue to find new ways to insert genes for specific traits into plant and animal DNA. A field of promise—and a subject of debate—genetic engineering is changing the food we eat and the world we live in.
In the brave new world of genetic engineering, Dean DellaPenna envisions this cornucopia: tomatoes and broccoli bursting with cancer-fighting chemicals and vitamin-enhanced crops of rice, sweet potatoes, and cassava to help nourish the poor.
Natural News) Most of America is still prohibited by the government from growing natural medicinal herbs (i.e., cannabis, psilocybin mushrooms, peyote) at home. That same government, however, is spending gobs of American tax dollars to develop artificial mRNA plant “vaccines” that Americans will be encouraged to consume and possibly even grow themselves in order to “protect” themselves against the latest designer “viruses.”
A recent announcement from the University of California, Riverside (UCR) explains that the National Science Foundation (NSF) gave a $500,000 taxpayer-funded grant to a group of scientists from UCR to genetically modify (GMO) new fruits and vegetables for Big Pharma that contain hidden vaccines inside their plant material.
“The future of vaccines may look more like eating a salad than getting a shot in the arm,” wrote Jules Bernstein in a school announcement about the project. “UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.”
Since existing mRNA vaccines in traditional vials have to be kept at very low temperatures in order to remain “viable,” getting them into people’s arms before they “expire” is a challenge. mRNA vegetables and fruits could solve this problem, scientists say.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” said Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Science who is heading up the research in conjunction with other scientists from the University of California San Diego (UCSD) and Carnegie Mellon University (CMU).
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens. Farmers could also eventually grow entire fields of it.”
In America, natural is “illegal” and unnatural is the norm
Giraldo further explained that the key to reprogramming plants to make artificial mRNA nanoparticles is to tamper with their chloroplasts.
These small plant cell organs normally convert sunlight into energy that plants then use to grow and thrive. After being manipulated by Giraldo and his ilk, these chloroplasts can be used to grow mRNA drugs for the pharmaceutical industry.
“They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo says. “They’re also an untapped source for making desirable molecules.”
By “desirable,” Giraldo of course means patentable and more importantly profitable. This plandemic operation is big money, after all, and once the injections they are calling “vaccines” fizzle out in popularity, the next step is to disguise them as fresh produce.
Mad scientists like Giraldo clearly believe that more people will be convinced to take “vaccines” if they look more like food as opposed to a metal syringe. And they are going to do everything within their power to achieve this goal.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” added Nicole Steinmetz, a UCSD professor of nanoengineering, about the abominable project.
“Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
Giraldo says it has long been a “dream” of his (talk about deranged…) to develop something like this. It has apparently been one of his lifelong goals to turn natural plants into artificial pharmaceutical factories.
“One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions,” he is quoted as saying. “Not just for food, but for high-value products as well, like pharmaceuticals.”
Giraldo is also working on a project to artificially engineer plants to inject their own nitrogen fertilizer straight into chloroplasts.
Yes, scientists are now studying whether or not they can turn edible plants into mRNA vaccine factories. In the March 24 episode of “War Room,” Pfizer whistleblower Karen Kingston talked about developing vaccines through food consumption.
“What [President Joe] Biden is saying is that in the New World Order, they’re gonna reduce the population, whether we are compliant with it or not,” Kingston said. She added that there’s evidence available that shows scientists have taken a chimera-weaponized mRNA and made it edible in lettuces, tomatoes and other forms of food.
“So what you’ll see in the media is like Medicago, which was just approved in Canada as a plant-based vaccine. Meaning, they actually use the cytoplasm in the plant to produce the mRNA,” Kingston explained.
Chimera is essentially a single organism that’s made up of cells from two or more “individuals.” In other words, it contains two or more sets of DNA.
The researchers talked about getting a half-million-dollar grant from the National Science Foundation. While not much is known from the ongoing research, there was a published work from back in 2006, in collaboration with scientists from Hong Kong, for SARS vaccination and spike protein.
The study states that the generation of transgenic plants – wherein they take plants and combine them with viruses from other species and animals – has successfully produced vaccines for cholera, Norwalk virus, hepatitis B and foot and mouth disease through coastal transmission.
However, the word “vaccine” in this case translates to the inoculation of the chimeric virus, so they are just being infected with the multispecies mRNA virus. In simpler terms, Kingston explained, “they’re basically putting the mRNA into the plants. They’re just taking man-made virus and putting it into plants.”
Vaccines that use edible plants as their delivery vehicle could yield them needle-free with no requirements for adjuvants (or chemicals that stimulate an immune response). When the plant is ingested, the plant cell walls can protect the vaccine antigens from degradation by stomach acids and digestive enzymes. Edible vaccines would also stimulate both mucosal and systemic immunity that provides a higher level of protection compared to the traditional injectable ones.
For instance, even though potatoes are viable options, there are not a lot of people who will eat a raw potato. If, for instance food is cooked, would the vaccines remain viable and effective? How can one ensure uniform products or determine the appropriate dose?
Other scientists also thought of producing edible vaccines in bananas or potatoes and processing them into a powder to make them more usable and consistent, but it is also unclear if this approach is commercially viable.
Follow Vaccines.news for more information about vaccines and their development.
Watch the video below to know more about [the plan to use food as vaccines]
** Canada approves Medicago's plant-based COVID-19 vaccine for adults**
By Amruta Khandekar
Feb 24 (Reuters) - Medicago's vaccine on Thursday became the world's first plant-based shot approved against COVID-19 after Health Canada cleared it for use in adults.
The two-dose vaccine, which uses an adjuvant from GlaxoSmithKline (GSK.L) to boost immune response, is the sixth COVID-19 shot to receive regulatory clearance in the country.
The Quebec-based privately held company has an agreement to supply up to 76 million doses of the vaccine to the Canadian government. Medicago said on Thursday it was committed to fulfilling the order as soon as possible.
"We're at a stage where we're ramping up capacity to meet the supply agreement," said Marc-André D’Aoust, executive vice president of innovation, development and medical affairs at Medicago.
The company will be sending material for fill/finish and packaging very soon, he added.
The home-grown vaccine, branded Covifenz, is based on a technology that uses plants in its development process to produce non-infectious particles that mimic the virus.
Medicago plans to test the shot as a booster dose and among children, D’Aoust said.
Its approval for people aged 18 to 64 years follows a late-stage study that showed the vaccine was 75.3% effective against the Delta variant of the virus.
The shot also showed an overall efficacy of 71% against all variants of the coronavirus except Omicron, which was not prevalent when the study was underway.
Medicago is preparing to study an Omicron-tailored version of its vaccine, D’Aoust said.
Canada has approved several vaccines including those based on mRNA technology from Moderna (MRNA.O) and Pfizer (PFE.N). Last week, the country cleared Novavax's (NVAX.O) protein-based shot for use in adults.
Medicago intends to apply for approval of the shot in Japan and is also in talks with the U.S. government and regulatory authorities in Europe and Asia for the vaccine, D’Aoust said.